BACKGROUND OF COVID-19

The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published 17.03.2020 in the journal Nature Medicine

The analysis of public genome sequence data from SARS-CoV-2 and related viruses found no evidence that the virus was made in a laboratory or otherwise engineered.

“By comparing the available genome sequence data for known coronavirus strains, we can firmly determine that SARS-CoV-2 originated through natural processes,” said Kristian Andersen, PhD, an associate professor of immunology and microbiology at Scripps Research and corresponding author on the paper.

In addition to Andersen, authors on the paper, “The proximal origin of SARS-CoV-2,” include Robert F. Garry, of Tulane University; Edward Holmes, of the University of Sydney; Andrew Rambaut, of University of Edinburgh; W. Ian Lipkin, of Columbia University.

Coronaviruses are a large family of viruses that can cause illnesses ranging widely in severity. The first known severe illness caused by a coronavirus emerged with the 2003 Severe Acute Respiratory Syndrome (SARS) epidemic in China.

A second outbreak of severe illness began in 2012 in Saudi Arabia with the Middle East Respiratory Syndrome (MERS).

On December 31 of last year, Chinese authorities alerted the World Health Organization of an outbreak of a novel strain of coronavirus causing severe illness, which was subsequently named SARS-CoV-2. As of February 20, 2020, nearly 167,500 COVID-19 cases have been documented, although many more mild cases have likely gone undiagnosed. The virus has killed over 6,600 people.

Shortly after the epidemic began, Chinese scientists sequenced the genome of SARS-CoV-2 and made the data available to researchers worldwide. The resulting genomic sequence data has shown that Chinese authorities rapidly detected the epidemic and that the number of COVID-19 cases has been increasing because of human to human transmission after a single introduction into the human population. Andersen and collaborators at several other research institutions used this sequencing data to explore the origins and evolution of SARS-CoV-2 by focusing in on several tell-tale features of the virus.

The scientists analysed the genetic template for spike proteins, armatures on the outside of the virus that it uses to grab and penetrate the outer walls of human and animal cells. More specifically, they focused on two important features of the spike protein: the receptor-binding domain (RBD), a kind of grappling hook that grips onto host cells, and the cleavage site, a molecular can opener that allows the virus to crack open and enter host cells.

Evidence for natural evolution

The scientists found that the RBD portion of the SARS-CoV-2 spike proteins had evolved to effectively target a molecular feature on the outside of human cells called ACE2, a receptor involved in regulating blood pressure. The SARS-CoV-2 spike protein was so effective at binding the human cells, in fact, that the scientists concluded it was the result of natural selection and not the product of genetic engineering.

This evidence for natural evolution was supported by data on SARS-CoV-2’s backbone — its overall molecular structure. If someone were seeking to engineer a new coronavirus as a pathogen, they would have constructed it from the backbone of a virus known to cause illness. But the scientists found that the SARS-CoV-2 backbone differed substantially from those of already known coronaviruses and mostly resembled related viruses found in bats and pangolins.

“These two features of the virus, the mutations in the RBD portion of the spike protein and its distinct backbone, rules out laboratory manipulation as a potential origin for SARS-CoV-2″ said Andersen.

Josie Golding, PhD, epidemics lead at UK-based Wellcome Trust, said the findings by Andersen and his colleagues are “crucially important to bring an evidence-based view to the rumours that have been circulating about the origins of the virus (SARS-CoV-2) causing COVID-19.”

“They conclude that the virus is the product of natural evolution,” Goulding adds, “ending any speculation about deliberate genetic engineering.”

Possible origins of the virus

Based on their genomic sequencing analysis, Andersen and his collaborators concluded that the most likely origins for SARS-CoV-2 followed one of two possible scenarios.

In one scenario, the virus evolved to its current pathogenic state through natural selection in a non-human host and then jumped to humans. This is how previous coronavirus outbreaks have emerged, with humans contracting the virus after direct exposure to civets (SARS) and camels (MERS). The researchers proposed bats as the most likely reservoir for SARS-CoV-2 as it is very similar to a bat coronavirus. There are no documented cases of direct bat-human transmission, however, suggesting that an intermediate host was likely involved between bats and humans.

In this scenario, both of the distinctive features of SARS-CoV-2’s spike protein — the RBD portion that binds to cells and the cleavage site that opens the virus up — would have evolved to their current state prior to entering humans. In this case, the current epidemic would probably have emerged rapidly as soon as humans were infected, as the virus would have already evolved the features that make it pathogenic and able to spread between people.

In the other proposed scenario, a non-pathogenic version of the virus jumped from an animal host into humans and then evolved to its current pathogenic state within the human population. For instance, some coronaviruses from pangolins, armadillo-like mammals found in Asia and Africa, have an RBD structure very similar to that of SARS-CoV-2. A coronavirus from a pangolin could possibly have been transmitted to a human, either directly or through an intermediary host such as civets or ferrets.

Then the other distinct spike protein characteristic of SARS-CoV-2, the cleavage site, could have evolved within a human host, possibly via limited undetected circulation in the human population prior to the beginning of the epidemic. The researchers found that the SARS-CoV-2 cleavage site, appears similar to the cleavage sites of strains of bird flu that has been shown to transmit easily between people. SARS-CoV-2 could have evolved such a virulent cleavage site in human cells and soon kicked off the current epidemic, as the coronavirus would possibly have become far more capable of spreading between people.

Study co-author Andrew Rambaut cautioned that it is difficult if not impossible to know at this point which of the scenarios is most likely, If the SARS-CoV-2 entered humans in its current pathogenic form from an animal source, it raises the probability of future outbreaks, as the illness-causing strain of the virus could still be circulating in the animal population and might once again jump into humans. The chances are lower of a non-pathogenic coronavirus entering the human population and then evolving properties similar to SARS-CoV-2.

The above article may throw some light about understanding of the evolved problems, without blaming any Scientists/Research Institutions/Countries.

We are to fight against the war of COVID-19 to save life and world for our next generation.

Flattening the curve refers to the urgent need to slow the rate of infection. Take a moment to learn how to do your part.

I can help by learning why this is so important practicing basic prevention.

The reason we hear so much about flattening the curve is because if we cannot slow the rate at which COVID-19 spreads, the health care system could become overwhelmed. This could mean a crucial shortage of doctors and hospital beds required to treat the ill. Luckily, with a few, simple good habits, like social distancing and thorough hand washing, we can flatten the curve!

Physics behind structural biology-An interdisciplinary research field

The novel coronavirus, SARS-CoV-2, has stretched to pandemic status. Scientists are tirelessly doing work to understand the virus activity and develop vaccines. The functionality, viral dynamics is still a mystery. Perhaps structural as well as macromolecule play an important role for understanding the viral activity. Function of biological macromolecules is possible to be explored through structural biology study. As the basis of drug design, structural biology helps determining viral structure since early 1990s. Hence physics comes forefront to device modern techniques such as automation and cryo-electron microscopy (cryo-EM).

Physics-based practices find enormous role in the field of structural biology. Mostly the structure of biological macromolecule is determined by X-ray crystallography, which starts in 1934, when John Desmond Bernal and Dorothy Hodgkin found the first X-ray pattern of a crystallized digestive enzyme pepsin. Later on, Dr. Hodgkin successfully applied X-ray crystallography to determine the structure of penicillin in 1946 and also obtained the structure of vitamin B12 in 1956 with the physics modality. One must tag the X-ray crystallographic determination as physics modality because it starts from the work of physicists such as Wilhelm Röntgen, who invented X-rays; Max von Laue, who revealed that X-ray wavelengths are in the range of inter-atomic distances and William Lawrence Bragg, who exhibited the utility of diffraction pattern for analysing the crystal structure. Dorothy Hodgkin put the X-ray crystallography in a very practical form for the determination of biological macromolecule, due to which, Hodgkin credited winner of the 1964 Nobel Prize for Chemistry

Besides, other modalities as application of physics driven working principle play important role in structural biology. They include NMR/I, electron microscopy, confocal microscopy, computation etc. In conjunction with molecular engineering these modalities are very efficient to explore macromolecular structures, energetics, and dynamics. Experimental strategies are supplemented by computational and theoretical approaches.

Nowadays, sequence and protein data are available. Biophysics are going to be a prime research field to apply different physical laws on the sequence data. Many theoretical approaches for analyzing protein structures, biomolecules are now an important tool to explore the structural biology. In this crisis period of COVID-19, physical theory is very helpful to understand the disease dynamics. It includes protein aggregation in cells, conformational dynamics of enzymes, cell penetration by viruses, DNA recognition by proteins, and protein folding. The experimental data are not sufficient to understand the virus infection, unless a solid background based on physical laws are taken much care of. Therefore, it is very important to establish interdisciplinary research field- Physics behind Structural Biology.

Entrepreneurship as an alternative to jobs

Given that India’s GDP growth has dropped below 5%, consumption is further dwindling due to pandemic corona virus outbreak, and GDP is further estimated to go down, and the world economy might go to a recession. Wages are not keeping with labour productivity, and unemployment is at a 45-year high, every means to counter this trend must be deployed. Promoting entrepreneurship among the youth to create employment, generate new wealth and boosting consumption is one of the answers. 

India’s startup ecosystem is not a recent need, but has been there for over decades and went through phases of evolution. Today, the startup ecosystem in India has seen a tremendous growth in both the quantum and variety, with an increasing advent of technology start-ups. In 2017, the country witnessed an addition of more than 1,000 tech start-ups, taking the total count of approximately 5,200 thereby strengthening its position as the third largest startup ecosystem across the world, after the USA and UK (NASSCOM).  

Inquisitive young minds are like soft clay forms easy moulds. Every young entrepreneur has an inquisitive mind, ready to experiment, prepared to learn and ready to take risks. Indian entrepreneurship and start-up scenario is changing phenomenally. There is amalgamation of synergy between talents, financial support, proactive government policies and an eco-system have resulted a favourable environment for entrepreneurship to germinate.

India has a multitude of successful start-ups in recent time such as, Flipkart, Ola Cabs, Oyo, WoW!Momo, Zomato, Pepperfry, Paytm, Byjus, Treebo Hotels, AddressHealth, FreshToHome, FreshMenu, Flyrobe, Myra, Cure.Fit, Dunzo, Shuttl, Urban Ladder, Cars24, Vedantu, Overcart, Doctor Insta, Cowrks, Meesho, Milk Basket, Policy Bazaar, Nykaa, Toppr, Travel Triangle, Cool Berg, The Minimalist, Nineleaps, and so on. These start-ups and several others have grown on the premise of technology and other critical resources, and have made enormous contribution in job creation and created wealth for the entrepreneur as well as for the country.

It’s the right time for start-ups, because government has gone an extra mile to facilitate administratively by relaxing various norms, networking and incubation support, financial support, long term tax holidays, thus enabling young entrepreneurs to take-up new ventures, and multiply job opportunities as job provider rather than job seekers. 

 Over the years, Indian economy has become increasingly supportive towards initiating business in the country. The fact can be validated by referring to the 2019 ‘Ease of Doing Business’ ranking released by World Bank, wherein, a total of 190 countries are assessed on various parameters. As per the rankings, India made significant improvement by reaching the 77th position from 100th in 2018. Several parameters witnessed improvement including starting a business, dealing with construction permits, trading across borders, getting electricity and credit facility.  

Amidst such encouraging entrepreneurial eco-systems and encouraging government support, gaining knowledge on entrepreneurial practices, getting familiar with the systems and frameworks promotes creative thinking among potential young entrepreneurs. Adamas University, School of Management has come forward in preparing such young entrepreneurs, who will embrace entrepreneurship as a career without any inhibition. We are confident that the knowledge, skills and incubation facilities provided to the bright young students will enable them to emerge as a successful entrepreneur of tomorrow. The bachelor and master degree on entrepreneurship offered by Adamas University, School of Management is an application-oriented programme which ensures evolution of individuals into a successful entrepreneur.  

Skip to content